Trading Into 2013: Zynga Inc, General Electric, World Moto, Mediswipe,
Advanced Cell Tech.
NEW YORK, January 7, 2013
NEW YORK, January 7, 2013 /PRNewswire/ --
The Stock Freak has a team of well diverse market professionals that has
combined experience of over 30 years that today are providing members with a
quick research report on 5 companies.
Zynga Inc (NASDAQ:ZNGA) - Zynga had an above average volume day on Friday as
the stock traded over 36 million shares to close at $ 2.63 representing a gain
of 9% from its previous close. On Jan 1^st 2013 Reginald Davis, Senior VP, GC,
Secretary of Zynga Inc bought 1,666 shares.
Whether bull or bear The Stock Freak has got you covered! Sign up to receive
our free newsletters and stay up to date with stocks on the run.
General Electric (NYSE:GE) - There was a total of 3 insider transactions on
Jan 2^nd the biggest being from Director John J. Bernnan, who bought 2949 at a
price per share of $21.20 for the total sum of $ 62,518.80
World Moto (OTC:FARE) - The company released news on Friday stating that
"Fast company.com has referred the Moto-meter as a 3 billion dollar idea" The
companies CEO Paul Giles go on to say that " $3 billion is just the beginning
of the industry World Moto can penetrate". The stock traded over 40 million
shares on Friday closing up 13%.
Advanced Cell Tech (OTC:ACTC) - ACTC traded more than double its average
volume on Friday. The stock traded just under 26 million shares closing up 31%
on the day.
Mediswipe Inc (OTC:MWIP) - The Company has been very active Last week
announcing that the headquarters would be moving to Michigan as the Marijuana
laws are less strict. Mediswipe Formally known as Cannabis medical solutions
still engages in medical marijuana. The stock traded over 45 million shares on
Friday and closed at $0.0289
To find similar research reports that are available for free follow the link
below and sign up at http://www.TheStockFreak.com
Disclosure: TheStockFreak.com is not a registered investment advisor and
nothing contained in any materials should be construed as a recommendation to
buy or sell securities. Investors should always conduct their own due
diligence with any potential investment. The Stock Freak is a wholly owned
entity of a financial public relations firm. Please read our report and visit
our website, for complete risks and disclosures.
Contact: Contact: Info@thestockfreak.com, 433 plaza real Suite 275, Boca
Raton, Fl, 33432, +1-561-372-8342
Press spacebar to pause and continue. Press esc to stop.